Literature DB >> 2784090

Relationship between neopterin and granulocyte elastase plasma levels and the severity of multiple organ failure.

R Pacher1, H Redl, M Frass, D H Petzl, E Schuster, W Woloszczuk.   

Abstract

In a series of 56 patients (24 uncomplicated postoperative and 32 septic patients), neopterin and elastase alpha 1 protease inhibitor complex (E-alpha 1 PI) plasma levels were measured daily. The clinical course of each patient was evaluated with the Multiple Organ Failure (MOF) score according to Goris. Neopterin could differentiate between septic and nonseptic patients (p less than .001), and E-alpha 1 PI between septic nonsurvivors and nonseptic patients only (p less than .01). In septic patients, acute pulmonary insufficiency was indicated by elevated E-alpha 1 PI values (greater than or equal to 400 micrograms/L) 1 day before mechanical ventilation was performed with a sensitivity of 81% and a specificity of 82%. Defining a patient with MOF whose score was greater than or equal to 5 as a high-risk septic patient, a comparison neopterin greater than or equal to 40 nmol/L and E-alpha 1 PI greater than or equal to 400 micrograms/L, measured 1 day before the evaluation of an MOF score of greater than or equal to 5 yielded a sensitivity of 91% and a specificity of 99% when patients fulfilled both criteria. We conclude that neopterin and E-alpha 1 PI might be useful parameters for the diagnosis of septicemia and monitoring of the clinical course in septic patients. Moreover, they might indicate the possible central role of macrophage and PMN activation in the development of MOF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784090     DOI: 10.1097/00003246-198903000-00004

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  14 in total

1.  Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity.

Authors:  P Rosenkranz-Weiss; W C Sessa; S Milstien; S Kaufman; C A Watson; J S Pober
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

2.  Evaluation of definitions and parameters for sepsis assessment in patients after cardiac surgery.

Authors:  G Pilz; S Kääb; E Kreuzer; K Werdan
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

3.  [Prospective validation of PMN-elastase as a prognostic parameter in the surgical intensive care unit].

Authors:  J Windolf; G Oremek; R Inglis; A Zega
Journal:  Unfallchirurgie       Date:  1994-10

4.  Hemostatic abnormalities and the severity of illness in patients at the onset of clinically defined sepsis. Possible indication of the degree of endothelial cell activation?

Authors:  B Leithäuser; F R Matthias; U Nicolai; R Voss
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

5.  PMN elastase in bone and joint infections.

Authors:  K M Peters; K Koberg; T Rosendahl; H D Haubeck
Journal:  Int Orthop       Date:  1994       Impact factor: 3.075

6.  Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis.

Authors:  Sacha Zeerleder; Christoph Caliezi; Gerard van Mierlo; Anke Eerenberg-Belmer; Irmela Sulzer; C Erik Hack; Walter A Wuillemin
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

7.  Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: comparison to limited infection and cardiogenic shock.

Authors:  P Boekstegers; S Weidenhöfer; G Pilz; K Werdan
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

8.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

9.  Detection of neopterin, interleukin-6 and acute-phase proteins as parameters of potential monocyte activation in preoperative patients.

Authors:  W Haupt; W Hohenberger; P Klein; N V Christou
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

10.  Leukocyte activation by isolated hyperthermic liver and limb perfusion due to malignancy.

Authors:  J P Arnestad; A Bengtsson; J P Bengtson; L Hafström; H Redl; G Schlag
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.